Peptides that flag liver problems

These 4 profiles mention liver problems in their Risks & interactions section, from the FDA label for approved drugs or from published studies for research compounds. Open a profile and read that section to see exactly why.

A peptide that isn't listed may simply have no human safety data, which doesn't make it safe for you. Dashed tags on investigational GLP-1 drugs come from the labels of approved drugs in the same class. Not medical advice: talk to a doctor or pharmacist about your own situation. All peptides · Heart or blood pressure problems · Blood thinners or bleeding problems · Diabetes or blood-sugar medicines · Cancer, now or in the past · Pregnancy or breastfeeding · Kidney problems

Cosyntropin

Cosyntropin is a synthetic ACTH fragment used in adrenal testing. The selected research paper examined a separate experimental obstetric application after accidental dural puncture.

Prescription medicines

Read the risks →

Pasireotide

Pasireotide is a somatostatin analogue studied in Cushing disease. The selected trial measured cortisol control and reported frequent hyperglycemia-related events.

Prescription medicines

Read the risks →

Terlipressin

Terlipressin is a vasopressin-related medicine used in a specific hepatorenal-syndrome setting. Its kidney-function results must be considered with the risk of serious respiratory complications.

Prescription medicines

Read the risks →

Triptorelin

Triptorelin is a GnRH agonist used for hormone suppression in clinical settings. The featured breast-cancer analysis included several ways of achieving ovarian suppression.

Prescription medicines

Read the risks →

See something wrong on this page? Report a mistake · Corrections